SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results
Go back to SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results| (NASDAQ: SABS) | Delayed: 3.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.71 | 52 Week High | $ | |||
| Open | $3.71 | 52 Week Low | $ | |||
| Day High | $3.71 | P/E | N/A | |||
| Day Low | $3.71 | EPS | $ | |||
| Volume | 8 | |||||
| (NASDAQ: SABSW) | Delayed: 0.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $ | |||
| Open | $0.02 | 52 Week Low | $ | |||
| Day High | $0.02 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $ | |||
| Volume | 8 | |||||
